Navigation Links
Corgenix Receives Additional European Patent, Announces Publication of Important Clinical Study on AtherOx(R) Technology
Date:6/22/2010

DENVER, June 22 /PRNewswire-FirstCall/ -- Corgenix Medical Corporation (OTC Bulletin Board: CONX), a worldwide developer and marketer of diagnostic test kits, announced today the issuance of one new European patent for the company's AtherOx® (oxLDL/B2GPI) technology and the publication of an important clinical trial studying oxLDL/B2GPI levels in patients with acute coronary syndrome (ACS).

"We are very pleased to announce these two very important accomplishments," said Douglass Simpson, President and CEO of Corgenix. "The newest patent expands our IP portfolio, and the acute coronary syndrome clinical trial reported remarkable results. Since cardiovascular disease is one of the world's leading causes of death, the early detection of atherosclerosis has become increasingly important, and we are optimistic about the ability of AtherOx to address this significant market."

The clinical trial was conducted at Saint Mary's Hospital in Waterbury, Conn., under the leadership of Thomas P. Greco, M.D.

European patent # EP 1 596 198 B, "Method of Measuring Oxidized LDL-Beta2-GP1-CRP Complex" was issued April 7, 2010. The patent is a method patent providing additional European protection to the components and assay procedure used to measure AtherOx complexes in biological samples. The latest patent adds to previous issued U.S. and European patents.

The clinical study, "Oxidized-LDL/B2-Glycoprotein I Complexes Are Associated With Disease Severity and Increased Risk for Adverse Outcomes in Patients With Acute Coronary Syndromes," was published in the American Journal of Clinical Pathology, 2010; 133:737-743.


'/>"/>
SOURCE Corgenix Medical Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Corgenix to Exhibit AspirinWorks(R) Test at Pri-Med New York
2. Corgenix and Tulane Announce Award of Additional NIH Contract to Expand Lassa Fever Research Towards Development of Vaccines and Improved Therapeutic Agents
3. Corgenix Secures $1,750,000 Asset Based Credit Facility Representing Initial Gross Proceeds of $1.109 Million
4. Corgenix Reports Third Quarter Fiscal 2009 Financial Results
5. Corgenix to Exhibit AspirinWorks(R) Test at ACC.09
6. Corgenix Reports Second Quarter Fiscal 2009 Financial Results
7. Corgenix to Host Conference Call to Discuss Second Quarter Results
8. Corgenix Signs Collaboration With Battelle
9. Corgenix Receives Two Additional Patents on AtherOx(R) Technology
10. Corgenix to Host Conference Call to Discuss First Quarter Results
11. Corgenix to Exhibit AspirinWorks(R) Test, Discuss New CHARISMA Trial Results at AHA 2008 Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... Selexis SA, a serial innovation company ... (RCBs) used for drug discovery to commercial manufacturing, announced ... Next-Generation Sequencing (NGS) data packages. The NGS ... by ensuring the integrity of the gene, validation of ...
(Date:1/22/2015)... , Jan. 22. 2015  Varian Medical Systems (NYSE: ... been honored for its commitment to sustainability with inclusion on ... is the highest ranked healthcare equipment company among the Corporate ... the World Economic Forum at Davos, Switzerland ...
(Date:12/24/2014)...  United Therapeutics Corporation (NASDAQ: UTHR ) announced ... has submitted a pre-market approval application to the U.S. ... Medtronic,s SynchroMed ® II implantable drug infusion system ... Therapeutics, Remodulin ® (treprostinil) Injection delivered intravenously to ...
(Date:12/24/2014)... “Preparative & Process Chromatography Market by Instrument ... Buffers, Valves, Guages, Seals), Accessories, Services, End User ... 2019” provides a detailed overview of the major ... strategies impacting the preparative and process chromatography market ...
Breaking Biology Technology:Selexis Generated Research Cell Banks Now Fully Sequenced Using Next-Generation Sequencing 2Varian Honored Among World's 100 Most Sustainable Corporations 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 2Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 3Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 4
... Pharmaceuticals, Inc. (NYSE: WPI ) today announced ... from the United States Food and Drug Administration on ... tablets, the generic equivalent to Roche,s BONIVA® tablets. Watson ... quarter. BONIVA® 150mg tablets had total U.S. sales of ...
... 2012 Creative Bioscience, a leading maker of dietary supplements ... African Mango Lean ™, African Mango 1200 ™, ... and its new Raspberry Ketone 1234 ™ weight loss ... Markets locations across the West and Southwest. ...
...  The San Diego entrepreneur group Bootstrappers Breakfast ( www.bootstrappersbreakfast.com ... a.m. on the last Friday of every month. The ... breakfast" is Friday, March 30 at 7:30 a.m. at ... Attendees, all with an entrepreneurial streak, discuss innovative ways to ...
Cached Biology Technology:Watson's Generic BONIVA® 150mg Receives FDA Approval 2Creative Bioscience All-Natural Dietary Supplements Now Available at Sprouts Farmers Market 2Creative Bioscience All-Natural Dietary Supplements Now Available at Sprouts Farmers Market 3Entrepreneurs to Eat Problems for Breakfast in San Diego 2
(Date:12/11/2014)... Dec. 09, 2014 Research and Markets ... http://www.researchandmarkets.com/research/twhjll/biometrics_market ) has announced the addition of the ... their offering. One major trend emerging ... advances in technology, it is important to upgrade biometric ...
(Date:12/11/2014)... 2014  Data Sciences International (DSI), the global leader ... series of digital telemetry implants to meet the ... part of the PhysioTel™ Digital platform, was designed ... data when incorporating functional endpoints into repeat-dose toxicology ...
(Date:12/10/2014)... , Dec. 9, 2014  Wake Forest Baptist Medical Center today ... School of Medicine. Funding for this $50 million capital project ... publicly launched next summer. The medical education ... Reynolds Tobacco Company complex, adjacent to 525@vine in Wake Forest ...
Breaking Biology News(10 mins):Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2New telemetry implants expected to change how large animal toxicology studies are conducted 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4
... 2, 2012 Biochemist and geneticist Alexander Varshavsky (California Institute ... lived in the USA since 1977, has been awarded the ... Molecular Biology (GBM). That medal is considered to be the ... By means of genetic research carried out with yeast and ...
... among his most vibrant and celebrated works, Vincent van Gogh,s ... basis has, until now, been a mystery. In a study ... of Georgia scientists reveal the mutation behind the distinctive, thick ... more than 100 years ago. The most common sunflower ...
... parasite, less resistance can sometimes be better than more, a ... known as Daphnia dentifera endures periodic epidemics of ... percent of the Daphnia population. During these epidemics, the ... A new study led by Georgia Institute of Technology ...
Cached Biology News:Otto Warburg Medal for Alexander Varshavsky 2Otto Warburg Medal for Alexander Varshavsky 3Genetic mutation depicted in van Gogh's sunflower paintings revealed by scientists 2Weakness can be an advantage in surviving deadly parasites, a new study shows 2Weakness can be an advantage in surviving deadly parasites, a new study shows 3
... Art GLP facility with capabilities from ... fermentation. Coordinated process development from ... operation capable of simultaneous production runs ... Hosts include: Bacteria, Yeast, Fungi, ...
Request Info...
Immunogen: VDAC3 Protein Storage: -20 C, Avoid Freeze/Thaw Cycles...
... 75 x 25 ... recommended for immunohistochemistry of paraffin-embedded sections, ... one end, markings will ... procedures, precleaned, ...
Biology Products: